| Literature DB >> 12810620 |
Rosalind J Jackson1, Robert W Engelman, Domenico Coppola, Alan B Cantor, Walker Wharton, W Jack Pledger.
Abstract
p21(Cip1) is a cyclin-dependent kinase inhibitor whose abundance increases in cells exposed to radiation or other DNA-damaging agents. Such increases activate a G1 checkpoint, which allows time for DNA repair before S phase entry. By inhibiting cell cycle progression, p21(Cip1) potentially suppresses tumorigenesis, and in support, we show that p21(Cip1) heterozygous and nullizygous mice develop more tumors than do wild-type mice when exposed to a single dose of gamma-irradiation. Importantly, we also show that p21(Cip1) nullizygosity increases the incidence of metastatic tumors in irradiated mice. We suggest that p21(Cip1) is haploinsufficient for tumor suppression and functions as an antimetastatic agent.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12810620
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701